A real-world pharmacovigilance study and pharmacological analysis of sulfasalazine based on the FDA adverse event reporting system (FAERS) database
database[Title] 2025-04-21
Summary:
CONCLUSION: This study revealed potential new AEs resulting from sulfasalazine, and further studies are needed to confirm these new AEs.